ArticleJournal of gastrointestinal oncology2021

The PRODIGE 7 randomized trial has 4 design flaws and 4 pharmacologic flaws and cannot be used to discredit other HIPEC regimens.

Paul H Sugarbaker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.